Bristol-Myers Squibb Appoints Charles Bancroft as Acting CFO

Bristol-Myers Squibb, a global biopharmaceutical company, has appointed Charles Bancroft as acting chief financial officer (CFO) and announced that Jean-Marc Huet, executive vice president and CFO, will leave the company at the end of 2009.

Bancroft was most recently vice president, finance for Bristol-Myers Squibb’s global biopharmaceutical business. In his new role, Bancroft will continue to report to Lamberto Andreotti, president and chief operating officer (COO).

Bancroft joined Bristol-Myers in 1984 and has since held positions of increasing responsibility within the finance organisation, including international assignments, senior leadership positions in the global pharmaceutical business and also with ConvaTec. He received his BS in Accounting from Drexel University, his MBA in Finance from Temple University, and is a certified public accountant (CPA).


Related reading